Rooftop solar players shut shop as going gets tough

By: |
Updated: July 19, 2019 7:15:34 PM

More than 12 EPC players in the rooftop solar segment have either closed or are on the verge of closing their rooftop solar divisions due to tough financial conditions.

Indian EPC, rooftop solar player, solar energy,  financial woes, Ujjas Energy, Kotak Urja, Relyon Solar, Harsha Abacus, Kirloskar Solar, 8 Minute, industry newsSome of the companies facing severe constraints are: Ujjas Energy, Kotak Urja and Relyon Solar, among others.

The falling margins and tariff pressure have forced Indian EPC rooftop solar players to shut shop over the last six months as they find it difficult to meet their working capital and other operating expenses, industry sources close to the development told FE.  Policy decisions from state to retrospectively cancel net metering, and failure to honour the 20% to 30% capital incentives have damaged the viability of many companies that aggressively bid for projects across the country, said sources close to the development.

More than 12 EPC players in the rooftop solar segment have either closed or are on the verge of closing their rooftop solar divisions due to tough financial conditions. Some of the companies facing severe constraints are: Ujjas Energy, Kotak Urja and Relyon Solar, among others.

Ketan Mehta, managing director of Rays Power Infra, which has re-strategised its focus on rooftop and is now opportunistically looking at commercial and industrial consumers under resco model, said “The policy uncertainty and reluctance from states to push rooftop segment providing long term clarity to this sector has led to negative sentiments across all stakeholders involved in this sector. Recent orders from states like UP, Tamil Nadu, and Maharashtra has further dampened the growth in this segment. Besides, there are very few financing options for individuals or SMEs. This has led to investment uncertainties and entry of foreign and risk capital in the sector.” “We have decided to focus on our core business of ground-mounted projects as the rooftop segment does not provide the bandwidth or the margins that we are comfortable with,” Mehta said. Emails or phone calls to other companies and their officials did not elicit any response till the time of going to press.

Rooftop solar was part of the 175 GW renewable target for 2022. However, the segment has failed to live up to the expectations. As of March 30, 2019, India has installed 4,375 MW of rooftop capacity with another 35,625 MW to be installed by 2022. Rahul Dasari, CEO of Sunshot Technologies, said: “Some of the reasons for poor performance of the rooftop solar sector have been non-payment of subsidies by government, which comprises 20% to 30% of the total capital cost, and non-payment of fees by off-takers. Besides, large number of players and lower tariffs have further reduced margins for small players, making the solar projects unsustainable.”

“States like UP have retrospectively cancelled the net metering policy, while Tamil Nadu discom TANGEDCO has not facilitated net metering, CEIG and no objection certificate (NOC) procedures are impacting solar projects in these states,” Dasari said. Under net metering, the developers can supply surplus power to grid. However, state discoms see that as threat to their business.

According to rating agency Icra, the receivable position for wind and solar power IPPs in Andhra Pradesh has worsened to about 8 to 10 months as of June 2019 against less than 4 months as on March 2018, exposing the IPPs in the state to higher credit risks. The rating agency further notes that the importance of honoring the PPAs has been emphasized by the Union ministry of new & renewable energy in the past through advisory directives to the state governments and by the judicial and regulatory authorities through various orders.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Next Stories
1Govt’s drug pricing formula comes under fire; activists seek method overhaul
2RBI rejects proposed appointment of ex-interim CEO, other on Religare’s board
32,500 drugs samples out of 76,000 examined found substandard in 2018-19